tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DYN Stock Latest News

Dyne Therapeutics price target raised to $43 from $39 at JPMorgan
The FlyDyne Therapeutics price target raised to $43 from $39 at JPMorgan
15d ago
DYN
Dyne Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
Dyne Therapeutics participates in a conference call with JPMorgan
30d ago
DYN
Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
PremiumPress Releases
Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
1M ago
DYN
Dyne announces new Pompe disease data showing potential of FORCE platform
PremiumThe Fly
Dyne announces new Pompe disease data showing potential of FORCE platform
1M ago
DYN
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
PremiumPress Releases
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
1M ago
DYN
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
PremiumPress ReleasesDyne Therapeutics to Present at Jefferies Global Healthcare Conference
2M ago
DYN
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
PremiumPress Releases
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
2M ago
DYN
Dyne Therapeutics price target raised to $39 from $25 at JPMorgan
PremiumThe Fly
Dyne Therapeutics price target raised to $39 from $25 at JPMorgan
2M ago
DYN
Dyne Therapeutics 10.5M share Secondary priced at $31.00
PremiumThe Fly
Dyne Therapeutics 10.5M share Secondary priced at $31.00
2M ago
DYN
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
PremiumPress Releases
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
2M ago
DYN
Dyne Therapeutics price target raised to $42 from $31 at Chardan
PremiumThe Fly
Dyne Therapeutics price target raised to $42 from $31 at Chardan
2M ago
DYN
Dyne Therapeutics files $300M common stock offering
PremiumThe Fly
Dyne Therapeutics files $300M common stock offering
2M ago
DYN
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
PremiumPress ReleasesDyne Therapeutics Announces Proposed Public Offering of Common Stock
2M ago
DYN
Dyne Therapeutics price target raised to $48 from $40 at Morgan Stanley
PremiumThe Fly
Dyne Therapeutics price target raised to $48 from $40 at Morgan Stanley
2M ago
DYN
Dyne Therapeutics price target raised to $42 from $36 at Jefferies
PremiumThe Fly
Dyne Therapeutics price target raised to $42 from $36 at Jefferies
2M ago
DYN
Dyne Therapeutics price target raised to $48 from $36 at H.C. Wainwright
PremiumThe Fly
Dyne Therapeutics price target raised to $48 from $36 at H.C. Wainwright
2M ago
DYN
Dyne Therapeutics price target raised to $45 from $37 at Guggenheim
PremiumThe Fly
Dyne Therapeutics price target raised to $45 from $37 at Guggenheim
2M ago
DYN
Dyne Therapeutics’ DYNE-101 shows efficacy in two Phase 1/2 trials
PremiumThe Fly
Dyne Therapeutics’ DYNE-101 shows efficacy in two Phase 1/2 trials
2M ago
DYN
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
PremiumPress Releases
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
2M ago
DYN
Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET
PremiumPress ReleasesDyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET
2M ago
DYN
Dyne Therapeutics reports Q1 EPS (81c), consensus (80c)
PremiumThe Fly
Dyne Therapeutics reports Q1 EPS (81c), consensus (80c)
3M ago
DYN
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
3M ago
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >